-
The authors concluded that in CAD patients, a history of CVE increased the risk of subsequent cardiovascular events, including hemorrhagic stroke.
-
The FDA has approved a buccal formulation of Acyclovir for the treatment of recurrent cold scores. The product uses a mucoadhesive technology that delivers the drug in high concentration to the site of the cold sore. Acyclovir buccal tablets are manufactured by Farmea in France and marketed as Sitavig by BioAlliance Pharma.
-
-
Mediterranean Diet Can Reduce Risk for Stroke; Low Levels of Light Exposure Associated with Higher Stroke Incidence
-
More patients who received a preventive medicine intervention also had their physician receive the corresponding preventive intervention.
-
-
Are OSA Outcomes Better in the Hands of Sleep Specialists than Primary Care Clinicians?; Inhaled Steroids Increase Risk of TB in COPD Patients
-
-
The national epidemic of substance abuse naturally imparts uncertainty and fear in the decision-making process regarding the prescribing of opioids for patients in pain. Statistics alone substantiate the need to validate our decisions with a documented plan of care.
-
Apixaban approval; new dental clinical practice guideline; apixaban for VTE; aspirin resistance; tamoxifen treatment; and FDA actions.
